Testosterone administration to men with testosterone deficiency syndrome after external beam radiotherapy for localized prostate cancer: preliminary observations.
about
Testosterone deficiency in the aging maleTestosterone Replacement Therapy and Prostate Cancer IncidenceChallenges to treat hypogonadism in prostate cancer patients: implications for endocrinologists, urologists and radiotherapistsTestosterone replacement therapy and the risk of prostate cancerTestosterone replacement therapy in patients with prostate cancer after radical prostatectomyOff-label use of hormones as an antiaging strategy: a reviewCurrent state of practice regarding testosterone supplementation therapy in men with prostate cancerDiagnosis and management of testosterone deficiencyTestosterone therapy in men with prostate cancer: literature review, clinical experience, and recommendations.Risks and benefits of late onset hypogonadism treatment: an expert opinion.A survey of Canadian urologists' opinions and prescribing patterns of testosterone replacement therapy in men on active surveillance for low-risk prostate cancerTestosterone therapy and prostate cancer.Androgen regulation of prostate cancer: where are we now?Use of testosterone replacement therapy in patients with prostate cancer.Effect of testosterone administration to men with prostate cancer is unpredictable: a word of caution and suggestions for a registry.Testosterone replacement and prostate cancer.Testosterone replacement therapy in the setting of prostate cancer treated with radiation.Serum testosterone level, testosterone replacement treatment, and prostate cancer.To treat or not to treat with testosterone replacement therapy: a contemporary review of management of late-onset hypogonadism and critical issues related to prostate cancer.The safety of testosterone supplementation therapy in prostate cancer.Testosterone Therapy in Men With Prostate Cancer.Testosterone Therapy on Active Surveillance and Following Definitive Treatment for Prostate Cancer.Testosterone Therapy Among Prostate Cancer Survivors.Addressing the pressing issues related to testosterone administration to men with prostate cancer.Baseline serum testosterone in men treated with androgen deprivation therapy and radiotherapy for localized prostate cancer.Testosterone therapy and prostate cancer--safety concerns are well founded.Long-acting testosterone injections for treatment of testosterone deficiency after brachytherapy for prostate cancer.
P2860
Q26770414-449E0D5B-B61B-4AE7-9A70-188270CE9BF4Q26771774-4C96E51D-403B-4C32-9549-84D92BFB5FA7Q26773738-FFB40345-D4A0-4DF0-B3BE-936C46ACEE60Q26823279-ACA2FBF9-BC6B-4DC3-AF91-80542C5A2C37Q28285210-2C02433E-7E8E-49D6-AD2C-C96DC7464596Q33976165-51E03C45-40CC-4B65-9D13-318FDD74A8AEQ34293663-F969B508-FC75-4C5B-9293-BAF1FCD1E452Q36293061-8682CABA-6ED6-4A3C-851B-D432C3A3B453Q36293127-2F8108FA-3DA8-438D-84CB-03F3ECC50F6CQ37165019-E928978D-C94A-4053-87FD-9391650FA4BCQ37301641-DA32929E-71DD-44E9-8881-7951AB9DB393Q37531045-8EAD0BA9-4D4C-4DBA-96F1-4D608E77CEEBQ37836264-FF4B6F93-B0EE-49E9-91B5-6E06890E6996Q37848698-F6D2A7BB-D1A6-40CC-9365-EF6F30CFCDF3Q37868755-A24D6A6D-D470-4E66-AB15-909B5BE6A19FQ38037508-E4198A41-E50D-4A44-BA47-91BCCED6318BQ38042783-46418EC0-E3B6-4760-932F-3E6B4041909EQ38155496-A4FB2F5E-3D8F-4FA5-8967-30329A2DA53DQ38212063-73EE694C-2125-4860-A64F-0537B951D5D1Q38234728-1B6BA2A3-12AE-4E25-BFE8-6213B750875CQ38683604-7D8D77DE-9F29-4F90-B763-252590677B0DQ38739186-46A8E19B-5733-4DF8-B7F1-F756E4BF5956Q38913362-11584DE3-DBB8-4711-B7E4-642F6BA554A0Q41259705-94BC6E8F-7FDE-49BC-954C-83DC0DEC8546Q42537805-F8C7C7D0-11C3-4379-97B4-643F4C86DE3CQ43594011-71A733AF-255D-43FF-9090-2D787942B077Q45351575-3DB9E1BC-B842-419E-BBD9-CF38075D20AA
P2860
Testosterone administration to men with testosterone deficiency syndrome after external beam radiotherapy for localized prostate cancer: preliminary observations.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Testosterone administration to ...... cer: preliminary observations.
@en
Testosterone administration to ...... cer: preliminary observations.
@nl
type
label
Testosterone administration to ...... cer: preliminary observations.
@en
Testosterone administration to ...... cer: preliminary observations.
@nl
prefLabel
Testosterone administration to ...... cer: preliminary observations.
@en
Testosterone administration to ...... cer: preliminary observations.
@nl
P2093
P1433
P1476
Testosterone administration to ...... cer: preliminary observations.
@en
P2093
Alvaro Morales
Angela M Black
Laurel E Emerson
P356
10.1111/J.1464-410X.2008.07882.X
P577
2008-07-29T00:00:00Z